Clinical Trial Update: Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing insulin glargine/insulin glulisine regimen to insulin aspart/insulin aspart protamine 30/70 in patients with Type 2 diabetes; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin aspart (insulin aspart)
• Insulin glulisine (insulin glulisine)
• NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart mix 70/30)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED